François Vergez

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

J. Portais, J. Tamburini, C. Récher, 2017, Leukemia.

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia

C. Récher, R. Castellano, Y. Collette, 2015, Blood Cancer Journal.

Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.

I. Luquet, A. Bidet, J. Alliot, 2024, Leukemia research.